ClinicalTrials.gg
CompletedNCT03937167Updated Oct 19, 2022

Benefits of Group Psychotherapy Programs in the Treatment of Obesity

An interventional study of Psychotherapy group in Obesity, Psychotherapy and Psychotherapy, Group, sponsored by Hospital Universitario Infanta Leonor. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-10-19.

Sponsored by Hospital Universitario Infanta Leonor · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Jan 2017, registered Apr 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 390 studies in Obesity with a site in Spain — 95 open to participants now, 134 under way, 45 of them phase 3. Obesity · Spain.

Enrollment
129th of 332
180 · median 124
Started
2017
with 20 others
No phase
220 of 390
41 open now
Registered
131st of 390
by date

Among the 390 studies in Obesity with a site in Spain, this one is the 129th largest by enrollment of the 332 interventional ones that give a count, is one of 21 that started in 2017, is one of 220 with no phase, and was the 131st registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

95 of the 390 studies in Obesity with a site in Spain are open now. Recruiting first, the newest first:

90 more — sign in →

All 95 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 390 studies in Obesity with a site in Spain, or all of them as a file.
02

Study summary

Obesity has reached pandemic proportions in recent years, affecting not only the physical health, but also the mental health, of obese people. According to Spain's National Health Survey 2011-12, the prevalence of obesity in the adult population of Spain was 17%, having increased by 2.5% since 2006. Therefore, a constant and worrying increase in the prevalence of obesity is being observed, which is having a great impact, both individually, in terms of health and quality of life, and socially, inter alia, by raising health expenditure due to increased morbidity.

In this context, the desirability of a comprehensive approach that includes psychological intervention in attending obese patients (Rev Cochrane, 2006), has been given greater prominence. Paying attention to the emotional and psychopathological aspects related to obesity has proven to be an action that could have positive impact on obesity intervention models.

The aim of this project is to measure, through a clinical trial, the efficacy of a psychotherapy group program for obesity patients who are attended by the consulting endocrinologist at the Infanta Leonor Hospital (Madrid). The impact of body mass index, psychological wellbeing, psychopathology and quality of life of two experimental study groups will be compared, one a control group of patients that follows the standard treatment, the other an experimental group that follows not only the standard treatment, but also the psychotherapy group intervention program.

03

Conditions studied

  • Obesity
  • Psychotherapy
  • Psychotherapy, Group

Browse trials for

Keywords

  • obesity
  • Psychotherapy
  • Psychotherapy Group
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age older than 18 and younger than 65.
  • of 30 or higher.
  • Candidate to a specific obesity treatment.
  • Accept psychological attention.
  • Able to understand and consent participation.
  • Able to speak, write and read in Spanish.
  • Committed to assist weekly for 6 months

Non-inclusion Criteria:

  • Obesity related to a non- stabilized hormonal disorder.
  • Severe mental disorders requiring specific treatment resources.
  • Cognitive or sensitive deficits.
  • Having had bariatric surgery within last 2 years.

Exclusion criteria

Exclusion criteria:

  • Pregnancy during treatment
  • Bariatric surgery during treatment
  • Addictive disorder as a principal diagnosis.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (actual)

Study arms

  • No intervention
    Control

    Standard treatment at Hospital Infanta Leonor with Endocrinology and Psyquiatry

  • Experimental
    Completers

    Randomized to treatment AND complete treatment 14 sessions are needed

    Other: Psychotherapy group

  • No intervention
    Drop-out

    Randomized to treatment BUT do not assist or do not complete treatment Less than 14 sessions

Interventions

  • OtherPsychotherapy group

    Added to standard treatment patients will participate in a standardized group of psychological intervention. 21 sessions with 10 to 12 members closed-ended groups.

06

What researchers measure

Primary outcomes

  1. weight difference

    Difference between the initial and final weight in kilograms

    Time frame: 1 year

Secondary outcomes

  1. Global Severity Index (GSI)

    Global psychopathology measured by Symptom Checklist-90-Revised (SCL-90-R). T score.

    Time frame: 1 year

  2. Positive Symptom Distress Index (PSDI)

    Style of response to distress measured by Symptom Checklist-90-Revised (SCL-90-R). T score.

    Time frame: 1 year

  3. Positive Symptom Total (PST).

    count of all the items with non-zero responses at Symptom Checklist-90-Revised (SCL-90-R). T score.

    Time frame: 1 year

  4. Eating disorder risk (EDRC)

    disfunctional eating behavior assessed by Eating Disorders Inventory 3rd Edition (EDI-3). T score. It is an index calculated by combining 3 scales: drive for thinness, body dissatisfaction, and bulimia

    Time frame: 1 Year

  5. Physical quality of life

    perceived physical quality of life assessed by Quality of Life Cuestionnaire SF-36

    Time frame: 1 year

  6. Mental quality of life

    perceived mental or psychic quality of life assessed by Quality of Life Cuestionnaire SF-36

    Time frame: 1 year

  7. Mediterranean Diet Adherence

    Mediterranean Diet Adherence measured by Test KIDMED

    Time frame: 1 year

  8. Motivation to change

    Motivation to change assessed by University of Rhode Island Change Assessment (URICA). 4 scales are measured: precontemplation, contemplation, action and maintenance.

    Time frame: 1 year

07

Study locations

1 site
  • Hospital Universitario Infanta Leonor
    Madrid, 28031, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2017 to primary completion in Dec 2019, 35 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 35 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2019
First posted
May 3, 2019
StartActual
Jan 1, 2017
Primary completionActual
Dec 31, 2019
CompletionActual
Jun 30, 2020
Last update
Oct 19, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03937167
Lead sponsor
Hospital Universitario Infanta Leonor
Collaborators
Carlos III Health Institute
Responsible party
Javier Quintero (Psychiatry Department Head, Hospital Universitario Infanta Leonor) — Principal investigator
First posted
May 3, 2019
Start date
Jan 1, 2017
Primary completion
Dec 31, 2019
Completion
Jun 30, 2020
Last update
Oct 19, 2022

Study contacts

Miriam Félix, PhD
principal investigator · Study Principal Investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion